1.
Alessandra Fusco, Sara Colarusso, Marco Piscopo, Maria Rosaria Improta, Marco Corigliano. Short-term Cardio-Vascular Risk Score Changes in Type 2 Diabetic Patients on Empaglifozin: A Real-Life Clinical Experience. HROJ [Internet]. 2017 Jul. 28 [cited 2026 Nov. 14];4(3):46-5. Available from: https://openventio.us/index.php/HROJ/article/view/816